Recent Company News

• 10:50 PM ET Feb 11, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (205 total)

• 10:07 PM ET Feb 09, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (450 total)

• 10:07 PM ET Feb 08, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (571 total)

• 03:22 PM ET Feb 06, 2026
  

  Yorvipath (palopegteriparatide injection) gains approval from Health Canada for the Treatment of Chronic Hypoparathyroidism in Adults ($220.99, +3.61)

• 10:20 PM ET Feb 04, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (393 total)

• 10:11 PM ET Feb 03, 2026
  

  Teijin CFO Naohiko Moriyama to change role; effective 3-Feb (¥1537.0000, +34.5)

• 10:05 PM ET Feb 03, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (279 total)

• 09:49 PM ET Feb 03, 2026
  

  Teijin reports Q3 net income attributable (¥4.10B) vs year-ago ¥104.3B (¥1537.0000, +34.5)

• 10:11 PM ET Feb 01, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (179 total)

• 09:39 PM ET Jan 25, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (30 total)